AID Genomics
Healthcare Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
4293 Euclid Ave, Los Angeles, California...Phone Number
(234) 567-8910Website
www.aidgenomics.comRevenue
$51.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
3
3
2
1
About AID Genomics
AID Genomics is an international group of medical technology companies specializing in the diagnosis and therapy of cancer. In 2017, the company acquired GeneSort, a diagnostics company that develops and performs genomic and genetic testing for accurate and personalized cancer care. AID Genomics advanced testing platforms are developed by a leading team of experts in the fields of oncology, molecular biology, molecular pathology, genomics and bioinformatics. AID Genomics uses cutting edge technology to substantially improve cancer patients' survival rate and quality of life by offering an early detection process integrated with personalized preventive medicine.Explore more
AID Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AID Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if AID Genomics is spiking on competitors!
Product Launch: Get notified when AID Genomics launches new products
Funding: Get notified immidiatlly once AID Genomics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if AID Genomics has recently received funding, and reach out quickly before it becomes old news!
AID Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AID Genomics had a recent Job posting/layoffs
Earning: See what the market has to say on AID Genomics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AID Genomics
Recommended Actions
Find VP level buyers at AID Genomics
Find 2 more new buyers
Compare Similar Companies to AID Genomics
Compare insights from companies similar to AID Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AID Genomics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
AID Genomics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about AID Genomics.
AID Genomics Tech Stack
A closer look at the technologies used by AID Genomics
AID Genomics News & Media
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 25, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an implementation and equipment financing partnership with AID Genomics, a multi-national genomic R&D company and solut
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AID Genomics
Sign Up For FreeTo access detailed company insights
AID Genomics is an international group of medical technology companies specializing in the diagnosis and therapy of cancer. In 2017, the company acquired GeneSort, a diagnostics company that develops and performs genomic and genetic testing for accurate and personalized cancer care. AID Genomics advanced testing platforms are developed by a leading... Read More
